Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
On 25 January, Neuronet hosted an online meeting of its WG on Sustainability, moderated by
On 23 April, Fraunhofer SCAI launched a new COVID-19 knowledge space which hosts tools for
LIFE & BRAIN GmbH, a SME based in Bonn, Germany, and partner within the PHAGO
With the PHAGO (Inflammation and Alzheimer’s disease: modulating microglia function – focussing on TREM2 and
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
Neuronet’s communication team and our community of communication representatives are pleased to announce that we will celebrate our projects.
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.
Scientists have shed new light on how a gene called TREM2 influences the progression of Alzheimer’s disease in different ways in the early and later stages.